Aster DM Healthcare (NSE:ASTERDM, BOM:540975) has received approval from the Competition Commission of India for its proposed merger with Quality Care India, according to a Wednesday filing to the Indian stock exchanges.
The transaction also includes Quality Care India's private equity investors and shareholders- BCP Asia II TopCo IV and Centella Mauritius Holdings.
Before the merger, Aster will purchase a 5% stake in Quality Care India from BCP Asia and Mauritius Holdings. This transaction will be in consideration of a primary share issuance by Aster, the competition watchdog said in a separate statement.
On completion of the merger, investors including BCP Asia, Mauritius Holdings and some minority stakeholders, will hold a certain stake in the merged entity. However, Mauritius Holdings will have a less than 10% stake without control rights in Aster DM Quality Care.
The company's shares were up 2% in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。